{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:13:28Z","timestamp":1791976408313,"version":"4.4.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00482-016-0160-3","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T02:51:44Z","timestamp":1476931904000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Metamizol","Dipyrone (metamizole)"],"prefix":"10.1007","volume":"31","author":[{"given":"U. M.","family":"Stamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Gundert-Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Biermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Erlenwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mei\u03b2ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wirz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Stammschulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146:657\u2013665","journal-title":"Ann Intern Med"},{"issue":"1","key":"160_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","volume":"15","author":"E Andr\u00e8s","year":"2008","unstructured":"Andr\u00e8s E, Maloisel F (2008) Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol 15(1):15\u201321","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"160_CR3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/ehm.11.12","volume":"4","author":"E Andr\u00e8s","year":"2011","unstructured":"Andr\u00e8s E, Zimmer J, Mecili M, Weitten T, Alt M, Maloisel F (2011) Clinical presentation and manegement of drug-induced agranulocytposis. Expert Rev 4(2):143\u2013151","journal-title":"Expert Rev"},{"key":"160_CR4","first-page":"A1758","volume":"108","author":"Arzneimittelkommission der Deutschen \u00c4rzteschaft","year":"2011","unstructured":"Arzneimittelkommission der Deutschen \u00c4rzteschaft (2011) Agranulozytose nach Metamizol \u2013 sehr selten, aber h\u00e4ufiger als gedacht. Dtsch \u00c4rztebl 108:A1758\u2013A1759","journal-title":"Dtsch \u00c4rztebl"},{"key":"160_CR5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1177\/147323001003800419","volume":"38","author":"GW Basak","year":"2010","unstructured":"Basak GW, Drozd-Sokolowska J, Wiktor-Jedrzejczak W (2010) Update on the incidence of metamizole sodium-induced blood dyscrasias in Poland. J Int Med Res 38:1374\u20131380","journal-title":"J Int Med Res"},{"key":"160_CR6","unstructured":"http:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RI\/2009\/RI-metamizol.html . Zugegriffen: 18. Nov. 2015"},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"LS Blaser","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Kr\u00e4henb\u00fchl S, R\u00e4tz Bravo AE (2015) Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol 71:209\u2013217","journal-title":"Eur J Clin Pharmacol"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.3.5875.339","volume":"3","author":"LE B\u00f6ttiger","year":"1973","unstructured":"B\u00f6ttiger LE, Westerholm B (1973) Drug-induced blood dyscrasias in Sweden. Br Med J 3:339\u2013343","journal-title":"Br Med J"},{"issue":"2","key":"160_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","volume":"30","author":"BR Curtis","year":"2014","unstructured":"Curtis BR (2014) Drug-induced immune neutropenia\/agranulocytosis. Immunohematology 30(2):95\u2013101","journal-title":"Immunohematology"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/14740338.6.3.323","volume":"6","author":"E Garbe","year":"2007","unstructured":"Garbe E (2007) Non-chemotherapy drug-induced agranulocytosis. Expert Opin Drug Saf 6:323\u2013335","journal-title":"Expert Opin Drug Saf"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/ncomms5757","volume":"5","author":"JI Goldstein","year":"2014","unstructured":"Goldstein JI, Jarskog LF, Hilliard C et al (2014) Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun 5:4757","journal-title":"Nat Commun"},{"issue":"2","key":"160_CR12","first-page":"45","volume":"40","author":"E Haen","year":"2013","unstructured":"Haen E, H\u00f6ffler D, Stammschulte T (2013) T\u00f6dliche Agranulozytose unter Novaminsulfon \u2013 aus Fehlern lernen. Arzneimittelverordnung Prax 40(2):45\u201346","journal-title":"Arzneimittelverordnung Prax"},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00228-002-0465-2","volume":"58","author":"K Hedenmalm","year":"2002","unstructured":"Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58:265\u2013274","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"160_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/jcpt.12261","volume":"40","author":"F Hoffmann","year":"2015","unstructured":"Hoffmann F, Meinecke P, Freitag MH, Glaeske G, Schulze J, Schmiemann G (2015) Who gets dipyrone (metamizole) in Germany? Prescribing by age, sex and region. J\u00a0Clin Pharm Ther 40(3):285\u2013288","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"160_CR15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00228-013-1618-1","volume":"70","author":"M Huber","year":"2014","unstructured":"Huber M, Andersohn F, Bronder E, Klimpel A, Thomae M, Konzen C, Meyer O, Salama A, Schrezenmeier H, Hildebrandt M, Sp\u00e4th-Schwalbe E, Gr\u00fcneisen A, Kreutz R, Garbe E (2014) Drug-induced agranulocytosis in the Berlin case-control surveillance study. Eur J Clin Pharmacol 70(3):339\u2013345","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"160_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"M Huber","year":"2015","unstructured":"Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M, Konzen C, Kreutz R, Garbe E (2015) Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 71(2):219\u2013227","journal-title":"Eur J Clin Pharmacol"},{"key":"160_CR17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.165.8.869","volume":"165","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Vidal X, Ballarin E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165:869\u2013874","journal-title":"Arch Intern Med"},{"issue":"4","key":"160_CR18","doi-asserted-by":"crossref","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","volume":"10","author":"T K\u00f6tter","year":"2015","unstructured":"K\u00f6tter T, da Costa BR, F\u00e4ssler M, Blozik E, Linde K, J\u00fcni P, Reichenbach S, Scherer M (2015) Metamizole-associated adverse events: a systematic review and meta-analysis. PLOS ONE 10(4):e0122918","journal-title":"PLOS ONE"},{"key":"160_CR19","unstructured":"Sanofi Homepage. https:\/\/mein.sanofi.de\/Produkte\/Novalgin . Zugegriffen: 6. Jan. 2016"},{"key":"160_CR20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(03)12751-1","volume":"361","author":"P Sch\u00f6nhofer","year":"2003","unstructured":"Sch\u00f6nhofer P, Offerhaus L, Herxheimer A (2003) Dipyrone and agranulocytosis: what is the risk? Lancet 361:968\u2013969","journal-title":"Lancet"},{"issue":"48","key":"160_CR21","first-page":"A-2610","volume":"108","author":"PS Schonh\u00f6fer","year":"2011","unstructured":"Schonh\u00f6fer PS (2011) Verzerrung. Dtsch \u00c4rztebl 108(48):A-2610","journal-title":"Dtsch \u00c4rztebl"},{"key":"160_CR22","first-page":"3","volume":"6","author":"P Sch\u00f6nhofer","year":"2015","unstructured":"Sch\u00f6nhofer P, Schaaber J (2015) Berliner Wei\u03b2w\u00e4sche. Pharma-Brief 6:3\u20135","journal-title":"Pharma-Brief"},{"issue":"3","key":"160_CR23","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00482-015-0003-7","volume":"29","author":"J Schulze","year":"2015","unstructured":"Schulze J, Freitag MH, Glaeske G, Schmiemann G, Hoffmann F (2015) Schmerzmittelversorgung von Pflegeheimbewohnern mit und ohne Krebserkrankung. Schmerz 29(3):276\u2013284","journal-title":"Schmerz"},{"key":"160_CR24","first-page":"315","volume-title":"Arzneiverordnungs-Report","author":"U Schwabe","year":"2014","unstructured":"Schwabe U, Pfaffrath D (2014) Kapitel\u00a06.3 Nichtopioide Analgetika. In: Schwabe U, Pfaffrath D (Hrsg) Arzneiverordnungs-Report. Springer, Berlin, S 315\u2013319"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00106-014-2942-1","volume":"3","author":"T Sende","year":"2015","unstructured":"Send T, Westermann S, Eichhorn KWG, Jakob M (2015) Klinische Symptomatik der metamizolinduzierten Agranulozytose in der HNO. HNO 3:215\u2013219","journal-title":"HNO"},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.acpain.2007.08.025","volume":"9","author":"UM Stamer","year":"2007","unstructured":"Stamer UM, Soehle M, Park T\u2011W, Fischer M, Stuber F (2007) Anaphylactic reaction after intravenous dipyrone. Acute Pain 9:221\u2013227","journal-title":"Acute Pain"},{"issue":"9","key":"160_CR27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00228-015-1895-y","volume":"71","author":"T Stammschulte","year":"2015","unstructured":"Stammschulte T, Ludwig W\u2011D, M\u00fchlbauer B, Bronder E, Gundert-Remy U (2015) Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990\u20132012. Eur J Clin Pharmacol 71(9):1129\u20131138","journal-title":"Eur J Clin Pharmacol"},{"key":"160_CR28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","volume":"256","author":"The International Agranulocytosis and Aplastic Anemia Study","year":"1986","unstructured":"The International Agranulocytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. JAMA 256:1749\u20131757","journal-title":"JAMA"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.1996.tb01651.x","volume":"60","author":"JP Uetrecht","year":"1996","unstructured":"Uetrecht JP (1996) Reactive metabolites and agranulocytosis. Eur J Haematol Supp 60:83\u201388","journal-title":"Eur J Haematol Supp"},{"issue":"3","key":"160_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1024\/1661-8157\/a001916","volume":"104","author":"E Zeiner","year":"2015","unstructured":"Zeiner E, Blaser LS, Tisljar K, Heim D, Taegtmeyer A (2015) Fatale Agranulozytose nach Metamizol-Reexposition. Praxis 104(3):151\u2013154","journal-title":"Praxis"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-016-0160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-016-0160-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-016-0160-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:08:23Z","timestamp":1718834903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-016-0160-3"}},"subtitle":["\u00dcberlegungen zum Monitoring zur fr\u00fchzeitigen Diagnose einer Agranulozytose","Considerations on monitoring for early detection of agranulocytosis"],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s00482-016-0160-3","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]}}}